Magenta Therapeutics, Inc. (MGTA)
(Delayed Data from NSDQ)
$15.33 USD
+1.53 (11.09%)
Updated May 3, 2019 04:00 PM ET
After-Market: $15.30 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Dianthus Therapeutics, Inc. [MGTA]
Reports for Purchase
Showing records 1 - 20 ( 101 total )
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
FY22 Results; Strategic Alternatives Being Evaluated
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Clinical-Stage Biotech Company With a Solid Cash Position but Uncertain Future; Initiate With Neutral Rating
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Downgrading MGTA to NEUTRAL on MGTA-117 Safety Issues
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
KOL Highlights: Discussing Stem Cell Transplants with Dr. Sergio Giralt
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Dianthus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- ASH Day 3 Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D